AVocAdo Extract to Improve gLycemia in Individuals With Obesity (AVAIL)
Sponsor: Commonwealth Scientific and Industrial Research Organisation, Australia
A NA clinical study on Obesity, this trial is completed. The trial is conducted by Commonwealth Scientific and Industrial Research Organisation, Australia and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
May 2021 — May 2023 [monthly]
Recruiting NA
-
Apr 2021 — May 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Mar 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Commonwealth Scientific and Industrial Research Organisation, Australia
- Isagenix International LLC
- Prolongevity Technologies
- University of Adelaide
For direct contact, visit the study record on ClinicalTrials.gov .